Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (171-180 of 270) with videos related to

Pageof 27
Sort By:
The Journal of Urology|July 22, 2014
DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinomaWolfgang Jäger, Christian Thomas, Ladan Fazli, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Plos One|August 11, 2012
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsJing Jiao, Antreas Hindoyan, Shunyou Wang, et al.
Oncotarget|August 14, 2014
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growthYuh-Shyan Tsai, Chen-Li Lai, Chih-Ho Lai, et al.
Oncotarget|February 4, 2016
Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environmentElham Hosseini-Beheshti, Wendy Choi, Louis-Bastien Weiswald, et al.
The Journal of Urology|June 18, 2011
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional studyJesse K McKenney, Jeff Simko, Michael Bonham, et al.
BJU International|February 21, 2007
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomographyDonald T T Yapp, Janet Woo, Aileen Kartono, et al.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Nature Communications|July 23, 2024
Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signalingXia Sheng, Hatice Zeynep Nenseth, Su Qu, et al.
Pageof 27

Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
The Journal of Urology|July 22, 2014
DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinomaWolfgang Jäger, Christian Thomas, Ladan Fazli, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Plos One|August 11, 2012
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsJing Jiao, Antreas Hindoyan, Shunyou Wang, et al.
Oncotarget|August 14, 2014
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growthYuh-Shyan Tsai, Chen-Li Lai, Chih-Ho Lai, et al.
Oncotarget|February 4, 2016
Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environmentElham Hosseini-Beheshti, Wendy Choi, Louis-Bastien Weiswald, et al.
The Journal of Urology|June 18, 2011
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional studyJesse K McKenney, Jeff Simko, Michael Bonham, et al.
BJU International|February 21, 2007
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomographyDonald T T Yapp, Janet Woo, Aileen Kartono, et al.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Nature Communications|July 23, 2024
Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signalingXia Sheng, Hatice Zeynep Nenseth, Su Qu, et al.
Pageof 27